Clinical Trial Update: Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether continuing versus withdrawing adalimumab maintains remission in non-radiographic axial spondyloarthritis has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis
• Non-radiographic Axial Spondyloarthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Axial Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-04-30